Pharmacy groups oppose electronic pedigree bill
Executive Summary
Despite supporting some provisions, the National Association of Chain Drug Stores and the National Community Pharmacists Association urge rejection of legislation introduced by Reps. Steve Buyer, D-Ind., and Jim Matheson, D-Utah, that sets specific deadlines to implement drug tracking requirements (1"The Pink Sheet," April 21, 2008, p. 19). In a May 13 letter to the House Energy and Commerce Committee, the groups say they "cannot support H.R. 5839, or any other legislation that would mandate an unproven and unfunded electronic pedigree/track and trace system." They assert that track and trace systems are "many years away from full development" and "many years away from being reliable or operationally effective at the pharmacy level." Provisions the groups support include giving the FDA authority to seize and destroy all adulterated and misbranded drugs at the nation's port of entry and stronger licensure standards for wholesalers
You may also be interested in...
House Bill Requires Standard Numerical Identifiers For Drug Tracking By 2010
Legislation setting specific deadlines to implement drug tracking requirements was introduced April 17 by Reps. Steve Buyer, R-Ind., and Jim Matheson, D-Utah
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.